Investors Grab BTAI Even Lower Than Its Secondary Stock Offering
February 24, 2020 at 10:03 AM EST
Looking back to 4 days ago, BioXcel Therapeutics Inc (BTAI) priced a 2,000,000 share secondary stock offering at $32.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..